Our sarcoma nomograms are prediction tools designed to help patients and their physicians assess risk based on specific patient and disease characteristics. The nomograms calculate the likely outcomes after surgical treatment for sarcoma.
All results from these tools should be discussed with a physician and understood in the context of each patient’s program of care. Results are based on data from patients treated at MSK, a large research institution with surgeons who perform a high volume of sarcoma procedures.
Our synovial sarcoma nomogram is a tool designed to predict the likelihood of surviving three years and five years after being diagnosed with synovial sarcoma, based on clinical and pathologic factors known before surgery. This tool is not designed for patients who received chemotherapy with anthracycline and ifosfamide (AI) before or shortly after surgery, as the nomogram predictions may be inaccurate.
Our liposarcoma nomogram is a tool designed to predict the prognosis of a patient with liposarcoma, the most common soft tissue sarcoma, after the primary tumor has been removed by surgery. This tool predicts the likelihood of surviving five years and 12 years after surgery, based on the characteristics of the patient and the tumor, such as the specific liposarcoma histologic subtype.
Our sarcoma local recurrence nomogram is a tool designed to predict the likelihood of soft tissue sarcoma returning at the site of initial surgery after the tumor is removed through limb-sparing surgery if the patient does NOT receive radiation. The probability of local recurrence is calculated for both three years and five years after surgery.
Our nomogram for sarcoma-specific death after local recurrence is a tool designed to predict the likelihood of dying from sarcoma after local recurrence of the initially treated soft tissue sarcoma. This tool predicts the likelihood of dying one year, two years, three years, four years, and five years after recurrence.
Our postoperative sarcoma-specific death nomogram is a tool designed to predict the likelihood of dying from soft tissue sarcoma four years, eight years, and 12 years after surgical treatment for the disease.
Our desmoid fibromatosis local recurrence nomogram is a tool designed to predict the likelihood of survival without the desmoid tumor returning at the site of initial surgery after the tumor is removed through surgery. The probability of survival free of local recurrence is calculated for three years, five years, and seven years after surgery.